- News
Enables initiation of global EquilibriX-S trial later this year Critical milestone in development of novel bypass agent to restore coagulation,...
- Management TeamNews
News & events
News & events
- News
VarmX, a clinical-stage biotech company focusing on development of innovative approaches for the reversal of anticoagulation, today announced treatment of...
- News
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, has been awarded up...
- News
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that new...
- News
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment...
- News
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment...
- Scientific publications
Reversal of anticoagulation is important for safe usage of oral factor (F)Xa-inhibiting direct oral anticoagulants (FXa-DOACs).
...- News
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the completion...
- News
VarmX, Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, today announced...
- News
VarmX announces publication in Nature Communications of groundbreaking snake venom inspired approach to restore blood clotting in patients using anticoagulants...